Taken together, these findings suggest that chemotherapy-induced neutrophil accumulation and upregulation of Gas6 also occurs in liver metastasis of patients with CRC and thus, targeting Gas6 might improve therapeutic interventions in patients with pancreatic cancer and CRC. The gene discussed is GAS6; the disease is familial pancreatic carcinoma.